Imaging Techniques in Body MRI
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00362557|
Recruitment Status : Active, not recruiting
First Posted : August 10, 2006
Last Update Posted : September 1, 2015
Any patient already receiving a scheduled MR scan of the body for any clinical indication will be eligible for this program. If patients agree to participate in this program, it would require only a slightly longer examination time. This time would vary according to the body area/organ being visualized but would not exceed 30 minutes over the length of the clinical examination. Volunteers are eligible if they are willing to undergo an MR examination.
Patients would not be required to make any additional visits beyond their clinically-indicated visits. The study duration would vary according to the body area/organ visualized but would not exceed 30 minutes over the length of the clinical examination. Volunteers would be required to keep one study appointment to include one MR imaging examination.
There will be no interruption to the standard care given to patients who participate in this trial since the clinical portion of their examination will be completed prior to the study portion of the exam.
|Condition or disease||Intervention/treatment|
|Clinically Indicated MR Imaging||Device: MRI|
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||Imaging Techniques in Body MRI|
|Study Start Date :||September 2001|
|Estimated Primary Completion Date :||December 2017|
|Estimated Study Completion Date :||December 2018|
- Magnetic resonance signal [ Time Frame: At time of MRI ]Magnetic resonance imaging acquires signal from the human body. The signal will be measured at the time of the patient study. The amount of signal change will be measured between subjects.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00362557
|United States, Maryland|
|Johns Hopkins Hospital|
|Baltimore, Maryland, United States, 21287|
|Principal Investigator:||David A Bluemke, MD PhD||Johns Hopkins University|